2 02, 2024 Samantha Epistolio et al., Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis adlitterio663392024-04-10T14:33:34+02:00 Leggi di più
23 08, 2023 Maria Raffaella Ambrosio et al., Immune landscape and oncobiota in HPV-Associated Colorectal Cancer: an explorative study adlitterio663392023-10-17T09:35:51+02:00 Leggi di più
1 05, 2023 Elena Orlandi et al., Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal Cancer Patients Undergoing Neoadjuvant Treatment adlitterio663392023-10-17T09:07:00+02:00 Leggi di più
10 11, 2022 Beatrice Stefanelli et al., Concomitant Administration of Capecitabine and Folate Supplements: Need to Encourage Medication Reconciliation adlitterio663392023-05-26T12:22:03+02:00 Leggi di più
13 06, 2022 Monica Niger et al., MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers. adlitterio663392022-10-20T12:13:29+02:00 Leggi di più
13 05, 2022 Mario Caccese et al., Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study adlitterio663392022-10-20T12:16:20+02:00 Leggi di più
5 02, 2022 Marco Dell’Aquila et al., Does Locally Advanced Thyroid Cancer Have Different Features? Results from a Single Academic Center adlitterio663392022-10-20T14:21:38+02:00 Leggi di più
2 02, 2022 Nicola Personeni et al., Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study adlitterio663392022-10-20T14:50:13+02:00 Leggi di più
1 12, 2021 Maria Letizia Lai., Thyroid cancer in Sardinian pediatric patients: report of 63 cases and a review of the literature adlitterio663392022-10-20T15:08:37+02:00 Leggi di più
25 08, 2021 Valentina Guarnieri et. al., PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype. Diatech Pharmacogenetics2021-01-05T12:31:00+01:00 Leggi di più
